https://www.selleckchem.com/pr....oducts/nvp-bgt226.ht
Background The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a prospective analysis of an international database and here we examine front-line treatments and quality-of-life in patients with newly diagnosed Mycosis Fungoides (MF). Objectives a) differences in first-line approach according to the TNMB staging; b) parameters related to a first-line systemic approach; c) response rates and quality of life (QoL) measures. Patients and methods 395 newly diagnosed patients with early-stage MF (IA-IIA) w
Like
Comment
Share
